忆立福治疗多发梗塞性痴呆40例临床分析  

A clinical trial of YILIFU (aniracetam tablets) on 40 patients with multi-infarction dementia

作　　者：柴新生[1] 王春景 周承兰 

机构地区：[1]山东省精神卫生中心,250014 [2]济南市历城区精神卫生防治中心

出　　处：《山东精神医学》2002年第1期8-9,共2页Shangdong Archives of Psychiatry

摘　　要：目的 应用忆立福(阿尼西坦)对40例轻、中度多发梗塞性痴呆进行治疗,评价该药在治疗中的疗效和不良反应。方法 采用治疗前后临床疗效自身对照法。结果 治疗后HDS、MMSE、ADL、MQ均较治疗前有明显改善,治疗前后对比有显著性差异。结论 忆立福对多发梗塞性痴呆有较好的改善记忆障碍及提高日常生活能力的作用,且无明显副反应,安全性好。Objective To evaluate the efficacy and safety of Yilifu on patients with multi - infarction dementia (MID) .Method The comparison of data between pre - and post - treatment was conducted. Results After treatment, the scores of HDS, MMSE and MQ were significantly increased (P < 0.001), with the score of ADL significantly decreased (P <0.001) .Mild adverse effects appeared in 20% of the patients.Conclusion Yilifu is an effective and safe drug which may significantly improve memory disorders and activity of daily life of patients with mild to moderate MID.

关 键 词：忆立福 多发梗塞性痴呆 临床特点 药物疗法 不良反应 记忆障碍 日常生活能力 

分 类 号：R749.13[医药卫生—神经病学与精神病学] R977[医药卫生—临床医学]